CIK 0001787306 · Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812974255
- Phone
- 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,318,251
- in 11 filings, $2.1M under 10b5-1 plans
Net −$3,318,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-02 | Watanabe Todd See Remarks | Sale 10b5-1 | −20,739 | $20.04 | $416K | 846,440 |
| 2025-10-01 | Watanabe Todd See Remarks | Sale 10b5-1 | −15,000 | $18.91 | $284K | 876,440 |
| 2025-10-01 | Watanabe Todd See Remarks | Sale 10b5-1 | −9,261 | $20.02 | $185K | 867,179 |
| 2025-10-01 | Welgus Howard G. Director | Option exercise 10b5-1 | +9,538 | $1.68 | $16K | 109,744 |
| 2025-10-01 | Welgus Howard G. Director | Sale 10b5-1 | −9,538 | $18.92 | $180K | 100,206 |
| 2025-10-01 | Welgus Howard G. Director | Sale 10b5-1 | −462 | $18.92 | $9K | 99,744 |
| 2025-10-01 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −9,538 | 0 | ||
| 2025-09-09 | Watanabe Todd See Remarks | Sale 10b5-1 | −504 | $17.52 | $9K | 891,440 |
| 2025-09-08 | Watanabe Todd See Remarks | Sale 10b5-1 | −9,625 | $17.54 | $169K | 891,944 |
| 2025-09-04 | Matsuda Masaru See Remarks | Sale 10b5-1 | −36,130 | $16.16 | $584K | 161,234 |
| 2025-09-02 | Welgus Howard G. Director | Option exercise 10b5-1 | +10,000 | 110,206 | ||
| 2025-09-02 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $15.64 | $156K | 100,206 |
| 2025-09-02 | Welgus Howard G. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2025-08-21 | Burnett Patrick See Remarks | Sale 10b5-1 | −2,438 | $15.57 | $38K | 104,811 |
| 2025-08-19 | Burnett Patrick See Remarks | Sale 10b5-1 | −1,750 | $16.16 | $28K | 107,249 |
| 2025-08-08 | Burnett Patrick See Remarks | Sale 10b5-1 | −3,847 | $14.03 | $54K | 108,999 |
| 2025-08-04 | Watanabe Todd See Remarks | Sale 10b5-1 | −11,547 | $14.33 | $165K | 901,569 |
| 2025-08-04 | Burnett Patrick See Remarks | Sale 10b5-1 | −2,622 | $14.33 | $38K | 112,846 |
| 2025-08-04 | Vairavan Latha SVP Chief Financial Officer | Sale 10b5-1 | −89 | $14.33 | $1K | 65,015 |
| 2025-08-04 | Matsuda Masaru See Remarks | Sale 10b5-1 | −6,330 | $14.33 | $91K | 197,364 |
Page 10 of 13 · 241 trades